Daiichi Sankyo Co Ltd
TSE:4568
Daiichi Sankyo Co Ltd
Cost of Revenue
Daiichi Sankyo Co Ltd
Cost of Revenue Peer Comparison
Competitive Cost of Revenue Analysis
Latest Figures & CAGR of Competitors
Company | Cost of Revenue | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Daiichi Sankyo Co Ltd
TSE:4568
|
Cost of Revenue
-¥415.3B
|
CAGR 3-Years
-7%
|
CAGR 5-Years
-3%
|
CAGR 10-Years
-4%
|
|
Takeda Pharmaceutical Co Ltd
TSE:4502
|
Cost of Revenue
-¥1.4T
|
CAGR 3-Years
-13%
|
CAGR 5-Years
-17%
|
CAGR 10-Years
-11%
|
|
Otsuka Holdings Co Ltd
TSE:4578
|
Cost of Revenue
-¥626.2B
|
CAGR 3-Years
-12%
|
CAGR 5-Years
-7%
|
CAGR 10-Years
-4%
|
|
S
|
Shionogi & Co Ltd
TSE:4507
|
Cost of Revenue
-¥57.6B
|
CAGR 3-Years
-3%
|
CAGR 5-Years
-1%
|
CAGR 10-Years
3%
|
Chugai Pharmaceutical Co Ltd
TSE:4519
|
Cost of Revenue
-¥334.9B
|
CAGR 3-Years
-8%
|
CAGR 5-Years
-5%
|
CAGR 10-Years
-5%
|
|
Astellas Pharma Inc
TSE:4503
|
Cost of Revenue
-¥292.5B
|
CAGR 3-Years
-6%
|
CAGR 5-Years
0%
|
CAGR 10-Years
1%
|
See Also
What is Daiichi Sankyo Co Ltd's Cost of Revenue?
Cost of Revenue
-415.3B
JPY
Based on the financial report for Mar 31, 2024, Daiichi Sankyo Co Ltd's Cost of Revenue amounts to -415.3B JPY.
What is Daiichi Sankyo Co Ltd's Cost of Revenue growth rate?
Cost of Revenue CAGR 10Y
-4%
Over the last year, the Cost of Revenue growth was -14%. The average annual Cost of Revenue growth rates for Daiichi Sankyo Co Ltd have been -7% over the past three years , -3% over the past five years , and -4% over the past ten years .